Annual Operating Profit
$13.40 M
-$32.21 M-70.62%
31 December 2023
Summary:
Supernus Pharmaceuticals annual operaing income is currently $13.40 million, with the most recent change of -$32.21 million (-70.62%) on 31 December 2023. During the last 3 years, it has fallen by -$162.19 million (-92.37%). SUPN annual operating profit is now -92.37% below its all-time high of $175.60 million, reached on 31 December 2020.SUPN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$39.83 M
+$21.61 M+118.67%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly operating income is currently $39.83 million, with the most recent change of +$21.61 million (+118.67%) on 30 September 2024. Over the past year, it has increased by +$32.15 million (+418.47%). SUPN quarterly operating profit is now -29.31% below its all-time high of $56.34 million, reached on 30 September 2020.SUPN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$72.78 M
+$32.15 M+79.11%
30 September 2024
Summary:
Supernus Pharmaceuticals TTM operating income is currently $72.78 million, with the most recent change of +$32.15 million (+79.11%) on 30 September 2024. Over the past year, it has increased by +$46.44 million (+176.28%). SUPN TTM operating profit is now -58.55% below its all-time high of $175.60 million, reached on 31 December 2020.SUPN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.6% | +418.5% | +176.3% |
| 3 y3 years | -92.4% | +21.9% | -37.8% |
| 5 y5 years | -90.7% | +0.3% | -50.7% |
SUPN Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.4% | at low | at high | +337.1% | -37.8% | +1193.7% |
| 5 y | 5 years | -92.4% | at low | -29.3% | +337.1% | -58.5% | +1193.7% |
| alltime | all time | -92.4% | +121.7% | -29.3% | +305.4% | -58.5% | +215.0% |
Supernus Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $39.83 M(+118.7%) | $72.78 M(+79.1%) |
| June 2024 | - | $18.21 M(-528.8%) | $40.64 M(+622.3%) |
| Mar 2024 | - | -$4.25 M(-122.4%) | $5.63 M(-58.0%) |
| Dec 2023 | $13.40 M(-70.6%) | $18.99 M(+147.2%) | $13.40 M(-49.1%) |
| Sept 2023 | - | $7.68 M(-145.7%) | $26.34 M(+49.5%) |
| June 2023 | - | -$16.80 M(-576.0%) | $17.63 M(-62.1%) |
| Mar 2023 | - | $3.53 M(-88.9%) | $46.51 M(+2.0%) |
| Dec 2022 | $45.61 M(-42.6%) | $31.93 M(-3179.1%) | $45.61 M(+118.2%) |
| Sept 2022 | - | -$1.04 M(-108.6%) | $20.90 M(-61.7%) |
| June 2022 | - | $12.09 M(+359.3%) | $54.62 M(-19.6%) |
| Mar 2022 | - | $2.63 M(-63.5%) | $67.90 M(-14.6%) |
| Dec 2021 | $79.50 M(-54.7%) | $7.22 M(-77.9%) | $79.50 M(-32.0%) |
| Sept 2021 | - | $32.68 M(+28.9%) | $116.98 M(-16.8%) |
| June 2021 | - | $25.36 M(+78.2%) | $140.63 M(-12.6%) |
| Mar 2021 | - | $14.23 M(-68.2%) | $160.82 M(-8.4%) |
| Dec 2020 | $175.60 M(+18.2%) | $44.70 M(-20.7%) | $175.60 M(+2.3%) |
| Sept 2020 | - | $56.34 M(+23.7%) | $171.72 M(+10.7%) |
| June 2020 | - | $45.55 M(+57.0%) | $155.10 M(+1.9%) |
| Mar 2020 | - | $29.01 M(-28.9%) | $152.16 M(+2.4%) |
| Dec 2019 | $148.57 M(+2.9%) | $40.82 M(+2.7%) | $148.57 M(+0.7%) |
| Sept 2019 | - | $39.73 M(-6.7%) | $147.61 M(+1.6%) |
| June 2019 | - | $42.60 M(+67.5%) | $145.36 M(+5.0%) |
| Mar 2019 | - | $25.43 M(-36.2%) | $138.48 M(-4.1%) |
| Dec 2018 | $144.44 M(+45.1%) | $39.85 M(+6.4%) | $144.44 M(+4.0%) |
| Sept 2018 | - | $37.48 M(+4.9%) | $138.93 M(+12.2%) |
| June 2018 | - | $35.72 M(+13.8%) | $123.80 M(+8.5%) |
| Mar 2018 | - | $31.39 M(-8.6%) | $114.15 M(+14.7%) |
| Dec 2017 | $99.54 M | $34.34 M(+53.7%) | $99.54 M(+22.1%) |
| Sept 2017 | - | $22.34 M(-14.3%) | $81.49 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $26.07 M(+55.3%) | $78.99 M(+22.3%) |
| Mar 2017 | - | $16.79 M(+3.0%) | $64.57 M(+19.1%) |
| Dec 2016 | $54.22 M(+160.1%) | $16.30 M(-17.9%) | $54.22 M(+18.4%) |
| Sept 2016 | - | $19.84 M(+70.4%) | $45.80 M(+47.5%) |
| June 2016 | - | $11.64 M(+80.9%) | $31.05 M(+33.6%) |
| Mar 2016 | - | $6.44 M(-18.3%) | $23.25 M(+11.5%) |
| Dec 2015 | $20.84 M(-494.9%) | $7.88 M(+55.0%) | $20.84 M(+15.2%) |
| Sept 2015 | - | $5.08 M(+32.3%) | $18.09 M(+47.5%) |
| June 2015 | - | $3.84 M(-4.7%) | $12.27 M(+0.7%) |
| Mar 2015 | - | $4.03 M(-21.3%) | $12.18 M(-330.8%) |
| Dec 2014 | -$5.28 M(-91.5%) | $5.13 M(-796.3%) | -$5.28 M(-75.7%) |
| Sept 2014 | - | -$736.00 K(-119.6%) | -$21.76 M(-43.0%) |
| June 2014 | - | $3.76 M(-128.0%) | -$38.20 M(-33.5%) |
| Mar 2014 | - | -$13.42 M(+18.2%) | -$57.43 M(-7.2%) |
| Dec 2013 | -$61.92 M(+46.8%) | -$11.36 M(-33.9%) | -$61.92 M(-2.2%) |
| Sept 2013 | - | -$17.18 M(+11.0%) | -$63.30 M(+8.4%) |
| June 2013 | - | -$15.48 M(-13.6%) | -$58.42 M(+11.9%) |
| Mar 2013 | - | -$17.91 M(+40.5%) | -$52.20 M(+23.8%) |
| Dec 2012 | -$42.17 M(+11.7%) | -$12.74 M(+3.7%) | -$42.17 M(+6.3%) |
| Sept 2012 | - | -$12.29 M(+32.8%) | -$39.67 M(+6.4%) |
| June 2012 | - | -$9.26 M(+17.5%) | -$37.29 M(+2.4%) |
| Mar 2012 | - | -$7.88 M(-23.1%) | -$36.43 M(-3.5%) |
| Dec 2011 | -$37.75 M(-5.9%) | -$10.24 M(+3.3%) | -$37.75 M(-19.5%) |
| Sept 2011 | - | -$9.91 M(+18.1%) | -$46.90 M(+26.8%) |
| June 2011 | - | -$8.40 M(-8.7%) | -$36.98 M(+29.4%) |
| Mar 2011 | - | -$9.20 M(-52.6%) | -$28.59 M(+47.4%) |
| Dec 2010 | -$40.12 M(-1099.1%) | -$19.39 M(+41.1%) | -$19.39 M(+41.1%) |
| Dec 2009 | $4.02 M(-115.5%) | -$13.74 M | -$13.74 M |
| Dec 2008 | -$25.86 M(+35.8%) | - | - |
| Dec 2007 | -$19.05 M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual operating profit year-on-year change?
- What is Supernus Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly operating profit year-on-year change?
- What is Supernus Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM operating profit year-on-year change?
What is Supernus Pharmaceuticals annual operaing income?
The current annual operating profit of SUPN is $13.40 M
What is the all time high annual operating profit for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual operaing income is $175.60 M
What is Supernus Pharmaceuticals annual operating profit year-on-year change?
Over the past year, SUPN annual operaing income has changed by -$32.21 M (-70.62%)
What is Supernus Pharmaceuticals quarterly operating income?
The current quarterly operating profit of SUPN is $39.83 M
What is the all time high quarterly operating profit for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly operating income is $56.34 M
What is Supernus Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, SUPN quarterly operating income has changed by +$32.15 M (+418.47%)
What is Supernus Pharmaceuticals TTM operating income?
The current TTM operating profit of SUPN is $72.78 M
What is the all time high TTM operating profit for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM operating income is $175.60 M
What is Supernus Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, SUPN TTM operating income has changed by +$46.44 M (+176.28%)